Mallinckrodt
Purdue to pay over $8bn to settle opioid-related criminal claims
Claims relate to Purdue's involvement in fuelling the opioid addiction crisis
Mallinckrodt files for bankruptcy protection in the US
Bankruptcy filing will reduce debts related to legal liabilities
US piles pressure on Mallinckrodt over alleged Acthar fraud
Drugmaker allegedly underpaid rebates owed to Medicaid
Mallinckrodt reaches tentative $1.6bn opioid settlement
Agreement reached with a plaintiff's executive committee
FDA committee rejects Intellipharmaceutics’ opioid drug Aximris
Verdict closely follows rejection of Nektar’s opioid analgesic
Nektar’s opioid analgesic slammed with FDA panel rejection
Panelists unanimously rejected use of the chronic back pain drug
Antibiotic biotech Melinta files for bankruptcy
Worries over antibiotic business model continue to mount
J&J appeals Oklahoma opioid verdict, claiming ‘errors’ in trial
Cites misuse of public nuisance laws as grounds for appeal
Teva names new CFO and bulks up its opioid liability fund
Opioid liability issue overshadowed the company's Q3 results
UPDATED: Ohio opioid trial averted by last-minute settlement
Drug manufacturers reach settlement hours before trial set to begin
J&J proposes $4bn in cash to settle opioid crisis allegations
Upcoming federal trial puts a number of companies in the spotlight
